Please assess the completion status of the following clinical trial:

Trial Title: A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects must present with a clinical diagnosis of stable (at least 3 months) plaque-type psoriasis.~* Subjects with psoriasis involving 10 to 20% BSA, not including the face, scalp, groin, axillae and other intertriginous areas.~* Subjects must have an IGA grade of 3 (moderate) at the Baseline Visit~Exclusion Criteria:~* Current diagnosis of unstable forms of psoriasis including guttate, erythrodermic, exfoliative or pustular psoriasis.~* Other inflammatory skin disease that may confound the evaluation of the plaque psoriasis (e.g., atopic dermatitis, contact dermatitis, tinea corporis).~* Presence of pigmentation, extensive scarring, or pigmented lesions or sunburn which could interfere with the rating of efficacy parameters.~* History of psoriasis unresponsive to topical treatments.~* History of organ transplant requiring immunosuppression, HIV, or other immunocompromised state.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- DFD01 Spray (Type: EXPERIMENTAL): DFD01 Spray twice daily for 28 days
- Vehicle Spray (Type: PLACEBO_COMPARATOR): Vehicle Spray twice daily for 28 days
- Comp01 Lotion (Type: ACTIVE_COMPARATOR): Comp01 Lotion twice daily for 14 days
- Vehicle Lotion (Type: PLACEBO_COMPARATOR): Vehicle Lotion twice daily for 28 days

Based on this trial design, predict the completion outcome and termination type (if applicable).